{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:47:06Z","timestamp":1761662826064},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.vaccine.2009.12.077","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T09:03:34Z","timestamp":1263200614000},"page":"2458-2464","source":"Crossref","is-referenced-by-count":10,"title":["A novel canine favored CpG oligodeoxynucleotide capable of enhancing the efficacy of an inactivated aluminum-adjuvanted rabies vaccine of dog use"],"prefix":"10.1016","volume":"28","author":[{"given":"Jiling","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.12.077_bib1","unstructured":"WHO Expert Consultation on Rabies. First report. Geneva: World Health Organization; 2004. (WHO Technical Report Series; 931)."},{"issue":"1","key":"10.1016\/j.vaccine.2009.12.077_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/vbz.2008.0046","article-title":"Rabies in China: an update","volume":"9","author":"Hu","year":"2009","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2009.12.077_bib3","doi-asserted-by":"crossref","first-page":"S693","DOI":"10.1093\/clinids\/10.Supplement_4.S693","article-title":"Organization of mass vaccination for dog rabies in Brazil","volume":"10","author":"Bellotto","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.12.077_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0035-9203(93)90099-C","article-title":"Immune response to rabies vaccine in Alaskan dogs: failure to achieve a consistently protective antibody response","volume":"87","author":"Sage","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2009.12.077_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vetmic.2008.06.024","article-title":"Comparison of antibody responses after vaccination with two inactivated rabies vaccines","volume":"133","author":"Minke","year":"2009","journal-title":"Vet Microbiol"},{"issue":"8\u201310","key":"10.1016\/j.vaccine.2009.12.077_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1863-2378.2008.01126.x","article-title":"Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia","volume":"55","author":"Suzuki","year":"2008","journal-title":"Zoonoses Public Health"},{"issue":"9","key":"10.1016\/j.vaccine.2009.12.077_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0264-410X(91)90186-A","article-title":"Immune response to rabies vaccine in Thai dogs: a preliminary report","volume":"9","author":"Tepsumethanon","year":"1991","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.12.077_bib8","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1172\/JCI119308","article-title":"T cells and viral hepatitis","volume":"99","author":"Chisari","year":"1997","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.vaccine.2009.12.077_bib9","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.191.8.1263","article-title":"T cells in hepatitis B: viral control versus liver cell injury","volume":"191","author":"Rehermann","year":"2000","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.12.077_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1538\/expanim.57.1","article-title":"Protection of mice from rabies by intranasal immunization with inactivated rabies virus","volume":"57","author":"Yoneda","year":"2008","journal-title":"Exp Anim"},{"issue":"6522","key":"10.1016\/j.vaccine.2009.12.077_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.vaccine.2009.12.077_bib12","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.4049\/jimmunol.160.12.5898","article-title":"CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry","volume":"160","author":"Yi","year":"1998","journal-title":"J Immunol"},{"issue":"16","key":"10.1016\/j.vaccine.2009.12.077_bib13","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1073\/pnas.96.16.9305","article-title":"CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells","volume":"96","author":"Hartmann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2009.12.077_bib14","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.12.077_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0264-410X(98)00151-0","article-title":"CpG motifs as immune adjuvants","volume":"17","author":"Klinman","year":"1999","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2009.12.077_bib16","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0264-410X(99)00443-0","article-title":"CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans","volume":"18","author":"Davis","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.12.077_bib17","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.164.3.1617","article-title":"Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.12.077_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10875-004-6244-3","article-title":"CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I\/II study","volume":"24","author":"Cooper","year":"2004","journal-title":"J Clin Immunol"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2009.12.077_bib19","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/S0264-410X(02)00216-5","article-title":"CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D","volume":"20","author":"Rankin","year":"2002","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2009.12.077_bib20","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.vaccine.2008.01.043","article-title":"A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.12.077_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.vetimm.2004.08.004","article-title":"Identification of CpG oligodeoxynucleotide sequences that induce IFN-gamma production in canine peripheral blood mononuclear cells","volume":"102","author":"Kurata","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.12.077_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0165-2427(01)00410-X","article-title":"CpG oligodeoxyucleotides stimulate canine and feline immune cell proliferation","volume":"84","author":"Wernette","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2009.12.077_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-59672-8_1","article-title":"Mechanisms of action of CpG DNA","volume":"247","author":"Krieg","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.12.077_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.164.2.944","article-title":"Mechanism and function of a newly identified CpG DNA motif in human primary B cells","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.12.077_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0378-1135(00)00300-X","article-title":"Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeognuleotides","volume":"78","author":"Kamstrup","year":"2001","journal-title":"Vet Microbiol"},{"issue":"13","key":"10.1016\/j.vaccine.2009.12.077_bib26","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.molimm.2005.12.004","article-title":"Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA","volume":"43","author":"Lee","year":"2006","journal-title":"Mol Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.12.077_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0264-410X(02)00378-X","article-title":"CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein","volume":"21","author":"Ioannou","year":"2002","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2009.12.077_bib28","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1128\/JVI.76.18.9002-9010.2002","article-title":"The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides","volume":"76","author":"Ioannou","year":"2002","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.12.077_bib29","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.intimp.2006.03.009","article-title":"The efficacy of CpG oligodinucleotides, in combination with conventional adjuvants, as immunological adjuvants to swine streptococcic septicemia vaccine in piglets in vivo","volume":"6","author":"Linghua","year":"2006","journal-title":"Int immunopharmacol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.12.077_bib30","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/IAI.67.8.3719-3726.1999","article-title":"DNA as an adjuvant in vaccination against Leishmania major","volume":"67","author":"Stacey","year":"1999","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T16:59:40Z","timestamp":1711126780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0264410X10000137"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}